Cholangitis overview: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Historical Perspective== | ==Historical Perspective== | ||
Cholangitis was first described as a life-threatening disorder in 1877 by Charcot. In 1955, Reynolds and Dargan recognized that [[septic shock]] and mental status changes portended a poor outcome. (Reynolds’s Pentad). | Cholangitis was first described as a life-threatening disorder in 1877 by Charcot. In 1955, Reynolds and Dargan recognized that [[septic shock]] and mental status changes portended a poor outcome. (Reynolds’s Pentad). | ||
==Causes== | ==Causes== | ||
| Line 17: | Line 17: | ||
==Diagnosis== | ==Diagnosis== | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
Obtaining the history is the most important aspect of making a diagnosis of cholangitis. It provides insight into cause, precipitating factors and associated comorbid conditions. | |||
===Physical Examination=== | |||
Charcot's triad, which includes abdominal pain, jaundice, and fever is a set of three common findings in cholangitis. Reynold's pentad, which includes Charcot's triad and two other symptoms, septic shock and mental confusion, are also common markers in a physical examination for cholangitis. It is associated with significant morbidity and mortality. | |||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
Laboratory tests provide useful clues in the diagnosis of [[cholangitis]]. Some commonly conducted tests are [[complete blood count]], [[basic metabolic panel]], [[liver function tests]], [[blood culture]], and other body fluid culture. | Laboratory tests provide useful clues in the diagnosis of [[cholangitis]]. Some commonly conducted tests are [[complete blood count]], [[basic metabolic panel]], [[liver function tests]], [[blood culture]], and other body fluid culture. | ||
==X-Ray== | |||
[[X-rays]] are not the most useful tool in diagnosing cholangitis and are mainly used to obtain a visual impression of the [[biliary system]] once an [[endoscopic retrograde cholangiopancreatography]] (ERCP) has been conducted. | |||
===CT=== | ===CT=== | ||
CT | CT scans have a high sensitivity in localizing the site of obstruction for cholangitis. | ||
==MRI=== | |||
[[Magnetic resonance imaging]] (MRI) has become the standard method for morphological examination of the [[bile ducts]], particularly for diagnosing cholangitis. T1-weighted and T2-weight sequences offer different results. | |||
===Ultrasound=== | |||
[[Ultrasounds]] (US) are the primary imaging modality for cholangitis. An US is both sensitive and specific in demonstrating biliary dilatation. | |||
===Other Imaging Findings=== | |||
[[Magnetic resonance cholangiopancreatography]] (MRCP) and endoscopic sonography (EUS) are the most sensitive techniques to correctly determine the underlying cause and level of biliary obstruction in patients with acute cholangitis. [[Endoscopic retrograde cholangiopancreatography]] (ERCP) is also considered a gold standard test for biliary obstruction. | |||
===Other Diagnostic Studies=== | |||
[[Blood tests]] to check levels of liver enzymes are the first step in diagnosing cholangitis. Doctors can confirm the diagnosis using [[cholangiography]], which provides pictures of the [[bile ducts]]. | |||
===Diagnostic Criteria=== | ===Diagnostic Criteria=== | ||
| Line 67: | Line 85: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | |||
Antimicrobial therapy is indicated for acute cholangitis. Patients with community- acquired mild to moderate disease are treated with [[Cephalosporins]]. All other patients are treated with a combination of [[Metronidazole]] and either [[Imipenem|Imipenem-Cilastatin]], [[Meropenem]], [[Doripenem]], [[Piperacillin-Tazobactam]], [[Ciprofloxacin]], [[Levofloxacin]], or [[Cefepime]]. | |||
===Surgery=== | |||
===Primary Prevention=== | ===Primary Prevention=== | ||
Although reestablishing biliary drainage is the mainstay of treatment, [[antibiotics]] play an important role in the management of cholangitis. | |||
===Secondary Prevention=== | |||
Secondary prevention strategies for cholangitis include continued treatment of predisposing causes in appropriate patients. | |||
===Cost-Effectiveness of Therapy=== | |||
The most cost-effective technique to diagnose cholangitis is an ultrasound. | |||
==References== | ==References== | ||
Revision as of 20:00, 13 September 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]
|
Cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangitis overview On the Web |
|
American Roentgen Ray Society Images of Cholangitis overview |
Overview
Cholangitis is a clinically defined syndrome of fever, right upper quadrant pain and jaundice caused by infection of bile and inflammation of the biliary tree, usually due to obstruction and stasis.
Historical Perspective
Cholangitis was first described as a life-threatening disorder in 1877 by Charcot. In 1955, Reynolds and Dargan recognized that septic shock and mental status changes portended a poor outcome. (Reynolds’s Pentad).
Causes
Cholangitis is usually caused by a bacterial infection, which can occur when the duct is blocked by something, such as a gallstone or tumor. The infection causing this condition may also spread to the liver.
Epidemiology and Demographics
Parasites are commonly associated with cholangitis outside of the United States. Parasites associated with cholangitis include the Ascaris, Opisthorchis, Clonorchis, Fasciola and Echinococcus. Ascaris is thought to be the etiologic agent of recurrent pyogenic cholangitis (Oriental cholangiohepatitis) found in Hong Kong, Southeast Asia, Columbia, Italy and South Africa. As they migrate to the biliary tree, they bring gut flora with them predisposing to bacterial infection. Dying worms lead to inflammation, granulomatous scarring and fibrosis which may lead to biliary cirrhosis. Opisthorchis and Clonorchis are transmitted by raw fish in Asia, Europe and Siberia and “frequently” lead to the development of cholangiocarcinoma. Fasciola is transmitted by colonized watercress and does not predispose to cholangiocarcinoma.
Diagnosis
History and Symptoms
Obtaining the history is the most important aspect of making a diagnosis of cholangitis. It provides insight into cause, precipitating factors and associated comorbid conditions.
Physical Examination
Charcot's triad, which includes abdominal pain, jaundice, and fever is a set of three common findings in cholangitis. Reynold's pentad, which includes Charcot's triad and two other symptoms, septic shock and mental confusion, are also common markers in a physical examination for cholangitis. It is associated with significant morbidity and mortality.
Laboratory Findings
Laboratory tests provide useful clues in the diagnosis of cholangitis. Some commonly conducted tests are complete blood count, basic metabolic panel, liver function tests, blood culture, and other body fluid culture.
X-Ray
X-rays are not the most useful tool in diagnosing cholangitis and are mainly used to obtain a visual impression of the biliary system once an endoscopic retrograde cholangiopancreatography (ERCP) has been conducted.
CT
CT scans have a high sensitivity in localizing the site of obstruction for cholangitis.
MRI=
Magnetic resonance imaging (MRI) has become the standard method for morphological examination of the bile ducts, particularly for diagnosing cholangitis. T1-weighted and T2-weight sequences offer different results.
Ultrasound
Ultrasounds (US) are the primary imaging modality for cholangitis. An US is both sensitive and specific in demonstrating biliary dilatation.
Other Imaging Findings
Magnetic resonance cholangiopancreatography (MRCP) and endoscopic sonography (EUS) are the most sensitive techniques to correctly determine the underlying cause and level of biliary obstruction in patients with acute cholangitis. Endoscopic retrograde cholangiopancreatography (ERCP) is also considered a gold standard test for biliary obstruction.
Other Diagnostic Studies
Blood tests to check levels of liver enzymes are the first step in diagnosing cholangitis. Doctors can confirm the diagnosis using cholangiography, which provides pictures of the bile ducts.
Diagnostic Criteria
Shown below are the diagnostic criteria for acute cholangitis according to Tokyo guidelines:[1]
- The diagnosis is "suspected" in the case of the presence of one item in systemic inflammation with one item in either cholestasis or imaging findings.
- The diagnosis is "definite" in the case of the presence of one item in systemic inflammation, one item in cholestasis and one item in imaging.
| Clinical Manifestations | Changes from the baseline |
|---|---|
| Systemic inflammation | ♦ Fever >38℃ and/or shaking chills ♦ Evidence of inflammatory response: - WBC (×1000/μl) <4, or >10 - CRP (mg/dl) ≥1 |
| Cholestasis | ♦ Jaundice with total bilirubin ≥2 (g/dl ♦ Abnormal liver function tests: - ALP (IU) >1.5×STD - γGTP (IU) >1.5×STD - AST (IU) >1.5×STD - ALT (IU) >1.5×STD |
| Imaging findings | ♦ Biliary dilatation ♦ Evidence of the etiology (stricture, stone, stent etc.) on imaging (abdominal X-ray: KUB, abdominal USG, CT scan, MRI, MRCP and HIDA scan) |
Severity Assessment Criteria
The severity assessment criteria for acute cholangitis according to Tokyo guidelines is as follows.[1]
Grade III Acute Cholangitis
Grade III or severe acute cholangitis is characterized by the onset of dysfunction in at least one of the following:
- Cardiovascular system: decreased blood pressure that necessitate the administration of dopamine (>5 μg/kg/min) or norepinephrine
- Neurological system: abnormal consciousness
- Respiratory system: PaO2/FiO2 ratio <300
- Renal system: serum creatinine >2.0 mg/dl, decreased urine output
- Hepatic system: PT-INR >1.5
- Hematological system: platelet count < 100,000/mm3
Grade II Acute Cholangitis
Grade II or moderate acute cholangitis is characterized by the presence of any two of the following:
- Abnormal WBC count: >12,000/mm3, <4,000/mm3
- Fever ≥39°C
- Age ≥75 years
- Elevated total bilirubin ≥5 mg/dl
- Decreased albumin level <0.7 x STD
Grade I Acute Cholangitis
Grade I or mild acute cholangitis does not meet the criteria of neither grade II (moderate) or grade III (severe) acute cholangitis.
Treatment
Medical Therapy
Antimicrobial therapy is indicated for acute cholangitis. Patients with community- acquired mild to moderate disease are treated with Cephalosporins. All other patients are treated with a combination of Metronidazole and either Imipenem-Cilastatin, Meropenem, Doripenem, Piperacillin-Tazobactam, Ciprofloxacin, Levofloxacin, or Cefepime.
Surgery
Primary Prevention
Although reestablishing biliary drainage is the mainstay of treatment, antibiotics play an important role in the management of cholangitis.
Secondary Prevention
Secondary prevention strategies for cholangitis include continued treatment of predisposing causes in appropriate patients.
Cost-Effectiveness of Therapy
The most cost-effective technique to diagnose cholangitis is an ultrasound.
References
- ↑ 1.0 1.1 Mayumi, T.; Someya, K.; Ootubo, H.; Takama, T.; Kido, T.; Kamezaki, F.; Yoshida, M.; Takada, T. (2013). "Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis". J UOEH. 35 (4): 249–57. PMID 24334691. Unknown parameter
|month=ignored (help)